PC
LUMO

PointState Capital’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

PointState Capital’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,000
Closed -$2.46M – 181
2015
Q1 		$2.46M Buy
+5,000
New +$1.94M 0.03% 104

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

PointState Capital's LUMO Position: Q2 2016 in Review

PointState Capital sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2016, closing a stake of 30,589 shares — an estimated $5.01M sold.

PointState Capital first reported a position in LUMO in Q2 2013 and held it in 12 quarters. The position peaked at $29.7M in Q1 2014. 112 funds tracked by Wall St. Rank hold LUMO as of Q2 2016.

  • PointState Capital reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • PointState Capital sold 30,589 Lumos Pharma, Inc. Common Stock shares in Q2 2016, an estimated $5.01M.
  • PointState Capital first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 12 quarters.
  • PointState Capital's Lumos Pharma, Inc. Common Stock position peaked at $29.7M in Q1 2014.
  • 112 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2016.

Based on PointState Capital's 13F filing for Q2 2016, filed 15 Aug 2016.